# A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)

> **NCT07230119** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Beijing QL Biopharmaceutical Co.,Ltd** · enrollment: 744 (estimated)

## Conditions studied

- Overweight , Obesity

## Interventions

- **DRUG:** Zovaglutide dose 1
- **DRUG:** Zovaglutide dose 2
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07230119
- **Lead sponsor:** Beijing QL Biopharmaceutical Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03-08
- **Primary completion:** 2027-05-29
- **Final completion:** 2027-06-26
- **Target enrollment:** 744 (ESTIMATED)
- **Last updated:** 2025-12-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07230119

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07230119, "A Study of Zovaglutide in Subjects With Overweight or Obesity (HORIZON-1)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07230119. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*